Search

Industry partners

The project is financially supported by several industry partners.

2016

AbbVie

AbbVieLogo_071D49_116x21_ProductAndDiseaseAwareness

AbbVie, formed in 2013 following the separation from Abbott, has partnered with EFCNI since 2008 supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.

AbbVie aims to help patients live healthier lives and collaborate with diverse stakeholders on sustainable healthcare solutions for patients, caregivers and societies around the world.

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company whose mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. The company employs nearly 21,000 people worldwide and markets medicines in more than 170 countries.

Nestlé Nutrition

2011 Nestle SHSH_logo - EN

The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.

The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.

Philips Avent

2014 02 Logo PhilipsAVENT_EFCNI material

Since 1984, AVENT has been designing and manufacturing products that are inspired by nature and have been developed through extensive research and clinical trials. Now, as part of the Philips Group, the new Philips AVENT will continue to produce innovative solutions that make feeding and caring for your baby’s health and safety easier. Philips AVENT is delighted to be the No. 1 recommended brand by UK mums* with its products loved by mums and babies across the UK. Philips AVENT believes that breastfeeding is the best method of nutrition for babies and that women should be given as much information and education as possible regarding the benefits of breast milk. Philips AVENT believes that it is every mother’s right to make her own decision on how she feeds her baby – bottle, breast or a combination of both – and Philips AVENT will support her in whatever choice she makes.

Shire

2014 Shire_logo_blauw klein

Shire’s strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs. The company focuses on providing treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine and is developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmology.

2015

AbbVie

AbbVieLogo_071D49_116x21_ProductAndDiseaseAwareness

AbbVie, formed in 2013 following the separation from Abbott, has partnered with EFCNI since 2008 supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.

AbbVie aims to help patients live healthier lives and collaborate with diverse stakeholders on sustainable healthcare solutions for patients, caregivers and societies around the world.

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company whose mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. The company employs nearly 21,000 people worldwide and markets medicines in more than 170 countries.

Dräger

D_Mini_RGB

Dräger is an international leader in the fields of medical and safety technology.

The family-owned company was founded in Lübeck, Germany, in 1889. Over the past five generations, Dräger has evolved into a publicly traded, worldwide group.

The current product range of the medical division includes anesthesia workstations, ventilators for emergency, critical care as well as warming therapy for premature infants. Patient monitoring, IT solutions, accessories and consumables, ceiling supply units, light systems and central supply systems for medical gases complete the portfolio.

Dräger has about 11,000 employees worldwide and is currently present in more than 190 countries. The company has sales and service subsidiaries in over 40 countries. Its development and production facilities are based in Germany, Great Britain, Sweden, South Africa, the USA, Brazil, the Czech Republic and China.

Nestlé Nutrition

2011 Nestle SHSH_logo - EN

The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.

The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.

Philips Avent

2014 02 Logo PhilipsAVENT_EFCNI material

Since 1984, AVENT has been designing and manufacturing products that are inspired by nature and have been developed through extensive research and clinical trials. Now, as part of the Philips Group, the new Philips AVENT will continue to produce innovative solutions that make feeding and caring for your baby’s health and safety easier. Philips AVENT is delighted to be the No. 1 recommended brand by UK mums* with its products loved by mums and babies across the UK. Philips AVENT believes that breastfeeding is the best method of nutrition for babies and that women should be given as much information and education as possible regarding the benefits of breast milk. Philips AVENT believes that it is every mother’s right to make her own decision on how she feeds her baby – bottle, breast or a combination of both – and Philips AVENT will support her in whatever choice she makes.

Shire

2014 Shire_logo_blauw klein

Shire’s strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs. The company focuses on providing treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine and is developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmology.

2014

AbbVie

AbbVieLogo_071D49_116x21_ProductAndDiseaseAwareness

AbbVie, formed in 2013 following the separation from Abbott, has partnered with EFCNI since 2008 supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.

AbbVie aims to help patients live healthier lives and collaborate with diverse stakeholders on sustainable healthcare solutions for patients, caregivers and societies around the world.

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company whose mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. The company employs nearly 21,000 people worldwide and markets medicines in more than 170 countries.

Dräger

D_Mini_RGB

Dräger is an international leader in the fields of medical and safety technology.

The family-owned company was founded in Lübeck, Germany, in 1889. Over the past five generations, Dräger has evolved into a publicly traded, worldwide group.

The current product range of the medical division includes anesthesia workstations, ventilators for emergency, critical care as well as warming therapy for premature infants. Patient monitoring, IT solutions, accessories and consumables, ceiling supply units, light systems and central supply systems for medical gases complete the portfolio.

Dräger has about 11,000 employees worldwide and is currently present in more than 190 countries. The company has sales and service subsidiaries in over 40 countries. Its development and production facilities are based in Germany, Great Britain, Sweden, South Africa, the USA, Brazil, the Czech Republic and China.

Nestlé Nutrition

2011 Nestle SHSH_logo - EN

The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.

The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.

Philips Avent

2014 02 Logo PhilipsAVENT_EFCNI material

Since 1984, AVENT has been designing and manufacturing products that are inspired by nature and have been developed through extensive research and clinical trials. Now, as part of the Philips Group, the new Philips AVENT will continue to produce innovative solutions that make feeding and caring for your baby’s health and safety easier. Philips AVENT is delighted to be the No. 1 recommended brand by UK mums* with its products loved by mums and babies across the UK. Philips AVENT believes that breastfeeding is the best method of nutrition for babies and that women should be given as much information and education as possible regarding the benefits of breast milk. Philips AVENT believes that it is every mother’s right to make her own decision on how she feeds her baby – bottle, breast or a combination of both – and Philips AVENT will support her in whatever choice she makes.

Shire

2014 Shire_logo_blauw klein

Shire’s strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs. The company focuses on providing treatments in Neuroscience, Rare Diseases, Gastrointestinal, and Internal Medicine and is developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmology.

2013

AbbVie

AbbVieLogo_071D49_116x21_ProductAndDiseaseAwareness

AbbVie, formed in 2013 following the separation from Abbott, has partnered with EFCNI since 2008 supporting the organization’s efforts to increase awareness of the many challenges associated with preterm birth and improving the quality of care available for preterm infants.

AbbVie aims to help patients live healthier lives and collaborate with diverse stakeholders on sustainable healthcare solutions for patients, caregivers and societies around the world.

AbbVie (NYSE:ABBV) is a global, research-based biopharmaceutical company whose mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. The company employs nearly 21,000 people worldwide and markets medicines in more than 170 countries.

Dräger

D_Mini_RGB

Dräger is an international leader in the fields of medical and safety technology.

The family-owned company was founded in Lübeck, Germany, in 1889. Over the past five generations, Dräger has evolved into a publicly traded, worldwide group.

The current product range of the medical division includes anesthesia workstations, ventilators for emergency, critical care as well as warming therapy for premature infants. Patient monitoring, IT solutions, accessories and consumables, ceiling supply units, light systems and central supply systems for medical gases complete the portfolio.

Dräger has about 11,000 employees worldwide and is currently present in more than 190 countries. The company has sales and service subsidiaries in over 40 countries. Its development and production facilities are based in Germany, Great Britain, Sweden, South Africa, the USA, Brazil, the Czech Republic and China.

Nestlé Nutrition

2011 Nestle SHSH_logo - EN

The fantastic progress in the delivery and treatment of small and very small preterm infants presents new challenges for nutrition and care. Nestlé Nutrition has always invested in the research and development of products for specific nutritional needs. It has therefore created the world’s largest research center in the field and an international network of collaboration with doctors and scientists. Resulting solutions can be tailored to specific nutritional requirements, as is the case with the special stage concept, elaborated to suit the changing needs of a developing preterm infant. Nestlé Nutrition has also developed a protein (hydrolysate) that provides allergy prevention proven to be effective.

The first small patient ever given Henri Nestlé’s “infants’ flour” was, in 1867, a preterm infant the doctors had already given up on. Little Charles Wanner went on to live for more than sixty years.

We thank our industry partners for supporting this project.